Patents by Inventor Sabine Bahn

Sabine Bahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS
    Publication number: 20130059750
    Abstract: The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder.
    Type: Application
    Filed: January 28, 2011
    Publication date: March 7, 2013
    Applicant: PSYNOVA NEUROTECH LTD.
    Inventors: Sabine Bahn, Marlis Huebner
  • BIOMARKERS
    Publication number: 20130017970
    Abstract: The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder.
    Type: Application
    Filed: December 20, 2010
    Publication date: January 17, 2013
    Applicant: Psynova Neurotech Ltd.
    Inventors: Sabine Bahn, Yishai Levin, Emanuel Schwarz
  • BIOMARKERS
    Publication number: 20130012402
    Abstract: The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder.
    Type: Application
    Filed: December 20, 2010
    Publication date: January 10, 2013
    Applicant: Psynova Neurotech Ltd.
    Inventors: Sabine Bahn, Emanuel Schwarz
  • BIOMARKERS FOR SCHIZOPHRENIA OR OTHER PSYCHOTIC DISORDERS
    Publication number: 20120251553
    Abstract: The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder.
    Type: Application
    Filed: September 9, 2010
    Publication date: October 4, 2012
    Applicant: Psynova Neurotech Ltd.
    Inventors: Sabine Bahn, Yishai Levin
  • BIOMARKERS
    Publication number: 20120094858
    Abstract: The invention relates to a method of diagnosing or monitoring bipolar disorders, in particular bipolar I and bipolar II disorders, such as manic psychosis.
    Type: Application
    Filed: April 16, 2010
    Publication date: April 19, 2012
    Applicant: Psynova Neurotech Ltd.
    Inventors: Sabine Bahn, Emanuel Schwarz, Marlis Huebner
  • BIOMARKERS
    Publication number: 20120071340
    Abstract: The invention relates to a method of diagnosing or monitoring major depressive disorder.
    Type: Application
    Filed: February 26, 2010
    Publication date: March 22, 2012
    Applicant: PSYNOVA NEUROTECH LTD.
    Inventors: Sabine Bahn, Emanuel Schwarz
  • BIOMARKERS
    Publication number: 20120071339
    Abstract: The invention relates to a method of diagnosing or monitoring multiple sclerosis.
    Type: Application
    Filed: February 26, 2010
    Publication date: March 22, 2012
    Applicant: PSYNOVA NEUROTECH LTD.
    Inventors: Sabine Bahn, Emanuel Schwarz
  • BIOMARKERS
    Publication number: 20120040852
    Abstract: The present invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorders
    Type: Application
    Filed: October 8, 2009
    Publication date: February 16, 2012
    Applicant: Psynova Neurotech Ltd.
    Inventors: Yishai Levin, Lan Wang, Sabine Bahn
  • Methods and biomarkers for diagnosing and monitoring psychotic disorders
    Patent number: 7981684
    Abstract: A method of diagnosing or monitoring a psychotic disorder, or predisposition thereto, comprises measuring, in a sample taken from a subject, the level of a biomarker selected from clusterin precursor, inter ?-trypsin inhibitor, IgM, apolipoprotein A2 and ?2 H5 glycoprotein.
    Type: Grant
    Filed: January 21, 2008
    Date of Patent: July 19, 2011
    Assignee: Psynova Neurotech Limited
    Inventors: Yishai Levin, Sabine Bahn
  • METHODS AND BIOMARKERS FOR DIAGNOSING AND MONITORING PSYCHOTIC DISORDERS
    Publication number: 20110165554
    Abstract: A method of diagnosing or monitoring a psychotic disorder, or predisposition thereto, comprises measuring, in a sample taken from a subject, the levels of one or more peptide biomarkers listed herein.
    Type: Application
    Filed: December 18, 2008
    Publication date: July 7, 2011
    Applicants: Psynova Neurotech Limited, Cambridge Enterprise Limited
    Inventors: Yishai Levin, Sabine Bahn, Lan Wang, Emanuel Schwarz, George McAllister
  • Biomarkers for schizophrenia
    Patent number: 7838246
    Abstract: The present invention provides biomarkers for schizophrenic and bipolar disorders and methods of diagnosis, monitoring and screening associated with the biomarkers and kits for performing such methods.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: November 23, 2010
    Assignee: Psynova Neurotech Limited
    Inventors: Sabine Bahn, Jeffrey Huang
  • SECRETOGRANIN AND VGF PEPTIDE BIOMARKERS AND USES THEREOF
    Publication number: 20100291597
    Abstract: Secretogranin II and VGF peptides are biomarkers for major depressive disorder. They are useful in methods of diagnosing, monitoring and screening.
    Type: Application
    Filed: August 15, 2007
    Publication date: November 18, 2010
    Applicant: CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Sabine Bahn, Jeffrey T.-J. Huang
  • METHODS AND BIOMARKERS FOR DIAGNOSING AND MONITORING PSYCHOTIC DISORDERS
    Publication number: 20100129919
    Abstract: A method of diagnosing or monitoring a psychotic disorder, or predisposition thereto, comprises measuring, in a sample taken from a subject, the level of a biomarker selected from clusterin precursor, inter ?-trypsin inhibitor, IgM, apolipoprotein A2 and ?2 H5 glycoprotein.
    Type: Application
    Filed: January 21, 2008
    Publication date: May 27, 2010
    Inventors: Yishai Levin, Sabine Bahn
  • Biomarkers and Uses Thereof
    Publication number: 20100003694
    Abstract: The present invention provides biomarkers for schizophrenic and bipolar disorders and methods of diagnosis, monitoring and screening associated with the biomarkers and kits for performing such methods.
    Type: Application
    Filed: February 14, 2006
    Publication date: January 7, 2010
    Inventors: Sabine Bahn, Jeffrey Huang
  • Methods to Monitor, Diagnose and Identify Biomarkers for Psychotic Disorders
    Publication number: 20090286238
    Abstract: A stimulated or non-stimulated T-cell sample can be used to diagnose or monitor a psychotic disorder, to identify a biomarker, or as to test a considerate as a potential therapeutic agent.
    Type: Application
    Filed: December 4, 2006
    Publication date: November 19, 2009
    Inventors: Rachel M. Craddock, Sabine Bahn
  • Methods and Biomarkers for Diagnosing and Monitoring Psychotic Disorders
    Publication number: 20090176257
    Abstract: The invention relates to methods of diagnosing or monitoring a psychotic disorder in a subject comprising providing a test biological sample from the subject, performing spectral analysis on said test biological sample to provide one or more spectra, and, comparing the one or more spectra with one or more control spectra. The invention also relates to methods for diagnosing or monitoring psychotic disorders such as schizophrenic or bipolar disorders, comprising measuring the level of one or more biomarkers present in a biological sample taken from a test subject, said biomarkers being selected from the group consisting of transthyretin, ApoA1: VLDL, LDL and aromatic species such as plasma proteins. The invention also relates to sensors, biosensors, multi-analyte panels, arrays, assays and kits for performing methods of the invention.
    Type: Application
    Filed: October 18, 2006
    Publication date: July 9, 2009
    Inventors: Sabine Bahn, Jeffery T. -J Huang, Tsz Tsang
  • Biomarkers and methods for identification of agents useful in the treatment of affective disorders
    Publication number: 20090093430
    Abstract: Potential therapeutic, agent for the prevention, treatment or amelioration of an affective disorder, such as a bipolar disorder, depression or anxiety disorder are identified. Also provided are methods for diagnosing and monitoring affective disorders. The methods are based on changes in expression of one or more genes that are differentially expressed in affective disorders.
    Type: Application
    Filed: November 28, 2006
    Publication date: April 9, 2009
    Inventors: Helen Elizabeth Lockstone, Matthew Thomas Wayland, Margaret Ryan, Sabine Bahn
  • Biomarkers
    Publication number: 20080220530
    Abstract: The invention relates to methods for diagnosing or monitoring psychotic disorders such as schizophrenic or bipolar disorders, comprising measuring the level of one or more biomarker(s) present in a cerebrospinal fluid sample taken from a test subject, said biomarker(s) being selected from the group consisting of: glucose, lactate, acetate species and pH. The invention also relates to methods of diagnosing or monitoring a psychotic disorder in a subject comprising providing a test sample of CSF from the subject, performing spectral analysis on said CSF test sample to provide one or more spectra, and, comparing the one or more spectra with one or more control spectra. The invention also relates to sensors, biosensors, multi-analyte panels, arrays, assays and kits for performing methods of the invention.
    Type: Application
    Filed: June 5, 2006
    Publication date: September 11, 2008
    Inventors: Sabine Bahn, Jeffrey T. Huang, Tsz Tsang
  • Differential gene expression in schizophrenia
    Publication number: 20060150264
    Abstract: The invention relates to methods of identifying potential therapeutic agents for the prevention, treatment, or amelioration of schizophrenia, to methods of diagnosis of schizophrenia, to methods of identifying patients most likely to respond to a particular therapeutic treatment, to methods for selecting participants in clinical trials, and to methods of prevention, treatment, or amelioration of schizophrenia.
    Type: Application
    Filed: June 14, 2004
    Publication date: July 6, 2006
    Inventors: Sabine Bahn, Margaret Ryan, Stephen Huffaker